| Dr Rochelle Gene Catus, MD | |
|
12255 De Paul Dr, Ste 765, Bridgeton, MO 63044-2510 | |
| (314) 298-8646 | |
| (314) 291-8646 |
| Full Name | Dr Rochelle Gene Catus |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 12255 De Paul Dr, Bridgeton, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497747224 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | R7F34 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rochelle Gene Catus, MD 12255 De Paul Dr, Ste 765, Bridgeton, MO 63044-2510 Ph: (314) 298-8646 | Dr Rochelle Gene Catus, MD 12255 De Paul Dr, Ste 765, Bridgeton, MO 63044-2510 Ph: (314) 298-8646 |
News Archive
Oncologists are increasingly using information obtained from investigations of the tumor genome in order to find individualized therapies for patients. They specifically search the hereditary information of cancer cells for mutations that drive malignant growth. By now, targeted drugs against many of these cancer-typical cellular alterations have become available.
The U.S. Food and Drug Administration has announced that Brownwood Acres Foods Inc., Cherry Capital Services Inc. (doing business as Flavonoid Sciences) and two of their top executives have signed a consent decree that effectively prohibits the companies and their executives from manufacturing and distributing any products with claims in the label or labeling to cure, treat, mitigate or prevent diseases
A study published in the Jan 16 edition of the New England Journal of Medicine suggests that erythropoietin treatment may not provide neuroprotection for extremely premature babies.
Research Down Syndrome (RDS), a nonprofit foundation that is among the leading sources for funding of Down syndrome related cognitive research, is entering the second year of its national running program, Race for the Extraordinary, to help increase public awareness and funding for Down syndrome research. The mission of RDS is the development of safe and effective therapies to address the intellectual difficulties associated with Down syndrome.
Coherex Medical, Inc. today announced that it has closed a $16.5 million Series B Preferred Stock financing. After the close of this investment, Coherex has now raised nearly $28.0 million in equity financing from outside funding sources since inception.
› Verified 2 days ago
Sarah Kennedy, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3466 Mckelvey Rd, Bridgeton, MO 63044 Phone: 314-344-8100 | |
Yoram Hahn, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12255 De Paul Dr, Ste 320, Bridgeton, MO 63044 Phone: 314-344-8100 Fax: 314-344-8102 | |
Dr. Leslie A Scott, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12277 De Paul Dr Ste 305, Bridgeton, MO 63044 Phone: 314-344-7585 | |
Donna Ann Robey, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12255 De Paul Dr, Bridgeton, MO 63044 Phone: 314-344-8100 Fax: 314-344-8102 | |
Stephanie Lee Cogan-levy, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 12277 De Paul Dr, Ste 501s, Bridgeton, MO 63044 Phone: 314-739-8844 Fax: 314-739-5431 | |
Dr. Hamnah Tabassum Siddiqui, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12277 De Paul Dr Ste 305, Bridgeton, MO 63044 Phone: 314-344-7585 |